Kabra Drugs

quarterly
yearly
ParticularsSep '24Dec '24Mar '25Jun '25Sep '25
Revenue0.000.000.647.1719.94
Expenses0.400.540.257.6717.74
EBITDA-0.40-0.540.40-0.502.22
EBIT-0.40-0.540.39-0.502.21
Profit Before Tax-0.40-0.540.39-0.502.21
Net Profit-0.40-0.540.39-0.501.84
Financial Ratios
Operating Profit Margin0.00%0.00%0.00%-6.99%11.23%
Net Profit Margin0.00%0.00%0.00%-6.99%9.31%
Earning Per Share (Diluted)-0.39-0.530.21-0.210.77
Dividends Per Share0.000.000.000.000.00